Richard S Lindahl Emergent Bio Solutions Inc. (EBS) insider trading activity

Richard S Lindahl is EVP, Chief Financial Officer of Emergent BioSolutions Inc.. Currently has a direct ownership of 291,497 shares of EBS, which is worth approximately $2.95 Million. The most recent transaction as insider was on Nov 15, 2021, when has been sold 3,000 shares (Common Stock) at a price of $37.46 per share, resulting in proceeds of $112,380. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 291K

1.68% 3M change

70.46% 12M change

Total Value Held $2.95 Million

RICHARD S LINDAHL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2021	BUY Open market or private purchase	$112,380 $37.46 p/Share	3,000 Added 6.99%	39,919 Common Stock
May 08 2021	SELL Payment of exercise price or tax liability	$64,947 $61.62 p/Share	1,054 Reduced 2.78%	36,919 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$79,566 $97.15 p/Share	819 Reduced 2.11%	37,973 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$94,425 $93.49 p/Share	1,010 Reduced 2.54%	38,792 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	8,023 Added 16.78%	39,802 Common Stock
Feb 09 2021	SELL Payment of exercise price or tax liability	$311,341 $123.45 p/Share	2,522 Reduced 7.35%	31,779 Common Stock
Feb 09 2021	BUY Grant, award, or other acquisition	-	2,495 Added 6.78%	34,301 Common Stock

Also insider at

CMPX

Compass Therapeutics, Inc. Healthcare

Director

RSL